Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kanglaite injection plus platinum-based chemotherapy for advanced non-small cell lung cancer
ChiCTR1900024319Phase 4Suspended
- Sponsor
- Guang'anmen Hospital
- Start
- Mar 2019
- Countries
- 1
01
Overview
Phase 4, open-label trial of kanglaite in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Guang'anmen Hospital. Primary endpoint: Progression-free survival. Started Mar 2019; status: suspended.
02
Drugs
kanglaite
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ChiCTR1900024319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024319.